![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Present at the American Academy of Physical Medicine and Rehabilitation Annual Assembly
September 28, 2015 08:00 ET
|
Cara Therapeutics
SHELTON, Conn., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Present Data at the 8th World Congress on Itch
September 22, 2015 08:00 ET
|
Cara Therapeutics
SHELTON, Conn., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Initiates Phase 3 Program for I.V. CR845 in Acute Postoperative Pain
September 09, 2015 08:00 ET
|
Cara Therapeutics
First Pivotal Trial Will Evaluate I.V. CR845, Dosed Pre- and Postoperatively, in Patients Undergoing Abdominal Surgery
Top-line data expected in 1H'2016
SHELTON, Conn., Sept. 9, 2015 (GLOBE...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Webcast Presentation at 22nd Annual NewsMakers in the Biotech Industry Conference
September 03, 2015 08:00 ET
|
Cara Therapeutics
SHELTON, Conn., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Sponsor Symposium and Present Posters at PAINWeek
September 01, 2015 08:00 ET
|
Cara Therapeutics
Pain Experts to Discuss Developments in Kappa Opioid Receptor Agonists and the Future of Pain Management
Company to Present Positive Data From Phase 2 Acute Pain and Human Abuse Liability...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis
August 17, 2015 08:00 ET
|
Cara Therapeutics
SHELTON, Conn., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Reports Second Quarter 2015 Financial Results
August 10, 2015 16:01 ET
|
Cara Therapeutics
Reported statistically-significant positive top-line results from Phase 2 trial for I.V. CR845 in uremic pruritus
Completed successful public offering of common stock, raising net proceeds of...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
August 04, 2015 16:01 ET
|
Cara Therapeutics
SHELTON, Conn., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics to Announce Second Quarter 2015 Financial Results on August 10, 2015
August 03, 2015 16:30 ET
|
Cara Therapeutics
SHELTON, Conn., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to selectively...
![Cara Therapeutics logo](/news-release/logo/311292/0/311292.jpg?lastModified=12%2F09%2F2016%2023%3A24%3A14&size=2)
Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock
July 29, 2015 19:10 ET
|
Cara Therapeutics
SHELTON, Conn., July 29, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...